Evista drug for treatment of osteoporosis. The selection modulator of estrogenic receptors. It has a selective promoting effect at not reproductive tissues and a suppressing effect at reproductive tissues. The biological effect, as well as effect of estrogen, it is mediated by high-affinity linking with oestrogenic receptors and regulation of an expression of genes.